The Cancer Letter

The leading source for information on the issues that shape oncology since 1973

In Brief

ONS and other groups ask nurses to lead by example to promote advance care planning

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print
BYLINE
IN THIS ISSUE
DOWNLOAD PDFTABLE OF CONTENTS

Advance care planning is a process for patients and their families to discuss their wishes and goals of care for treatment and end-of-life care, clarify related values and goals, and state preferences through written documents and medical orders.

In situations where a patient’s decision-making capacity is limited, healthcare providers turn to family members to make decisions.

The Oncology Nursing Society has joined with nursing specialty organizations representing more than 700,000 nurses and other healthcare professionals to promote those ACP conversations among patients and families. The initiative encourages all nurses to lead by example by establishing their own ACP.

The initiative, tagged “#ISaidWhatIWant,” was developed in response to the work done at the 2017 Palliative Nursing Summit hosted by the Hospice and Palliative Care Nursing Association, in which ONS participated.

The summit brought nurses together from various specialties to develop a collaborative nursing agenda regarding ACP, pain and symptom management, and transitions/coordination of care.

Following the summit, participating organizations formed work teams to develop specific programs to influence public health by engaging nurses in targeted initiatives to enhance the care and outcomes for patients and their families.

Table of Contents

YOU MAY BE INTERESTED IN

Clinical

Oncofertility coverage mandates expand to 21 states and DC as political momentum builds
Gaps persist as patients face harrowing decisions and huge copays

The nagging pain in Mia Sandino’s right knee set in in September 2018, and throughout her freshman year at the University of Washington, she tried to ignore it. “I was being a very naive and invincible-feeling 19-year-old,” Sandino told The Cancer Letter. “I didn’t put two and two together that this area of the knee that...

By Claire Marie Porter and Sara Willa Ernst
Guest Editorial

My introduction to, and lessons learned from, Rick Pazdur

Rick Pazdur, MD, the newly appointed director for the Center for Drug Evaluation and Research at the FDA, has been described as “greyhound thin” as a result of his dedication to cycling and lifting weights in the gym each day and, for a long time, a vegetarian diet. I first met him when he was the director of the Office of Oncology Drug Products (ODP) within CDER, in 2009.
By Mikkael A. Sekeres
Table of Contents

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login

Site license subscribers:
Log in with your IP | Register a sponsored account